U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457775) titled 'Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS' on Feb. 05.
Brief Summary: The study is expected to include 24 patients with metastatic or surgically unresectable relapsed/refractory soft tissue sarcoma confirmed by histological evidence, who have received at least one line of systemic treatment previously. The efficacy and safety of liposome irinotecan combined with temozolomide and bevacizumab in the treatment of relapsed/refractory soft tissue sarcoma will be evaluated.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Soft Tissue Sarcoma (Excluding GIST)
I...